tiprankstipranks
scPharmaceuticals reports inducement grants under Nasdaq listing rule
The Fly

scPharmaceuticals reports inducement grants under Nasdaq listing rule

scPharmaceuticals announced that on February 1, 2023, the Compensation Committee of scPharmaceuticals’ board of directors granted inducement equity grants consisting of stock options to purchase an aggregate of 142,500 shares of its common stock to 38 new employees. These stock options are subject to the terms of the scPharmaceuticals Inc. 2023 Employment Inducement Award Plan. The Inducement Plan is used exclusively for the grant of equity awards to individuals as an inducement material to their entering into employment with scPharmaceuticals pursuant to Nasdaq Listing Rule 5635(c)(4). The Inducement Plan was adopted by scPharmaceuticals’ board of directors in February 2023. The stock options have an exercise price of $6.84 per share. Each option will vest as to 25% of the total number of shares subject to the option on the first anniversary of the applicable individual’s employment start date with the Company, with the remaining shares subject to the option vesting in 36 equal monthly installments thereafter, such that the shares subject to the option are fully vested on the fourth anniversary of the applicable individual’s employment start date with the Company.

Published first on TheFly

See today’s best-performing stocks on TipRanks >>

Read More on SCPH:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles